1. Home
  2. NEO vs BTSG Comparison

NEO vs BTSG Comparison

Compare NEO & BTSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • BTSG
  • Stock Information
  • Founded
  • NEO 2001
  • BTSG 1974
  • Country
  • NEO United States
  • BTSG United States
  • Employees
  • NEO N/A
  • BTSG N/A
  • Industry
  • NEO Precision Instruments
  • BTSG
  • Sector
  • NEO Health Care
  • BTSG
  • Exchange
  • NEO Nasdaq
  • BTSG NYSE
  • Market Cap
  • NEO 1.9B
  • BTSG 2.0B
  • IPO Year
  • NEO 1999
  • BTSG 2024
  • Fundamental
  • Price
  • NEO $14.11
  • BTSG $23.61
  • Analyst Decision
  • NEO Strong Buy
  • BTSG Strong Buy
  • Analyst Count
  • NEO 10
  • BTSG 13
  • Target Price
  • NEO $20.44
  • BTSG $19.54
  • AVG Volume (30 Days)
  • NEO 1.2M
  • BTSG 1.7M
  • Earning Date
  • NEO 02-18-2025
  • BTSG 02-14-2025
  • Dividend Yield
  • NEO N/A
  • BTSG N/A
  • EPS Growth
  • NEO N/A
  • BTSG N/A
  • EPS
  • NEO N/A
  • BTSG N/A
  • Revenue
  • NEO $644,118,000.00
  • BTSG $10,588,215,000.00
  • Revenue This Year
  • NEO $13.00
  • BTSG $29.14
  • Revenue Next Year
  • NEO $10.10
  • BTSG $10.84
  • P/E Ratio
  • NEO N/A
  • BTSG N/A
  • Revenue Growth
  • NEO 12.06
  • BTSG 25.72
  • 52 Week Low
  • NEO $12.13
  • BTSG $7.85
  • 52 Week High
  • NEO $19.11
  • BTSG $24.82
  • Technical
  • Relative Strength Index (RSI)
  • NEO 40.08
  • BTSG 70.65
  • Support Level
  • NEO $13.76
  • BTSG $23.00
  • Resistance Level
  • NEO $15.26
  • BTSG $24.82
  • Average True Range (ATR)
  • NEO 0.68
  • BTSG 1.20
  • MACD
  • NEO -0.02
  • BTSG 0.33
  • Stochastic Oscillator
  • NEO 7.85
  • BTSG 82.27

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

About BTSG BRIGHTSPRING HEALTH SERVICES INC

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment.

Share on Social Networks: